Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Secretin Articles

Repligen in profit for year-ending 2008

23 June 2008

Repligen narrows loss 87% in fiscal 4th-qtr

18 June 2007

Repligen's FY 2005 sees 35% sales rise

6 June 2005

Repligen's secretin fails to show efficacy

14 February 2005

Repligen's RG1068 fails in autism trial

5 January 2004

Pharmagene starts Ph II trial of PGN0052

22 December 2003

Repligen seeks to widen secretin use

3 June 2002

Repligen starts pivotal autism trial

25 February 2002

Repligen optimistic that its novel autism treatment can move forward

25 February 2002

Repligen plans pivotal trials of autism drug

5 November 2001

Repligen extends Ph II secretin trial in autism

21 June 2001

Repligen drug for autism misses mark

5 April 2001

Repligen begins Ph II with secretin in autism

6 April 2000

Autism treatment hope lifts Repligen

12 March 1999

Showing 1-14 of 14 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS